StocksPfizerPFE

PFE

Pfizer

49.84 0.13 (0.26%)
Precios retrasados ofrecidos por el índice NASDAQ, en USD Mercado cerrado
Invertir
V
49.83
C
49.95
Publicación incluida
Tiago Cipriano Vidal
🔴 𝐏𝐟𝐢𝐳𝐞𝐫 – 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐌&𝐀 𝐚𝐜𝐭𝐢𝐯𝐢𝐭𝐲 🔴 0️⃣ 𝐏𝐟𝐢𝐳𝐞𝐫 𝐢𝐬 𝐛𝐮𝐲𝐢𝐧𝐠 𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 According to WSJ, Pfizer is close to acquire Global Blood Therapeutics at $68.50 per share, valuing the company at 5.4B$. GBT specializes in sickle cell disease,... Mostrar más Traducir
Canal de mercado
Destacado
Steeve Esquis
⭐ 𝐒𝐈𝐌𝐏𝐋𝐘 𝐒𝐀𝐅𝐄 𝐃𝐈𝐕𝐈𝐃𝐄𝐍𝐃𝐒 𝐈𝐍𝐂𝐎𝐌𝐄 ⭐ 🎯 𝗖𝗼𝗺𝗽𝗮𝗻𝘆 𝗿𝗲𝘃𝗶𝗲𝘄 - Let's talk about LOW 🎯 𝗖𝗼𝗻𝘀𝘂𝗺𝗲𝗿 𝗗𝗶𝘀𝗰𝗿𝗲𝘁𝗶𝗼𝗻𝗮𝗿𝘆 𝘀𝗲𝗰𝘁𝗼𝗿 ›𝗛𝗼𝗺𝗲 𝗜𝗺𝗽𝗿𝗼𝘃𝗲𝗺𝗲𝗻𝘁 𝗥𝗲𝘁𝗮𝗶𝗹 Hi investors! In the same sector (Consumer Discretionary), which is reacting positively,... Mostrar más Traducir
Me gusta ComentarCompartir
1 respuesta
null
.
Gian Marco Nuvoli
UK: Britain became the first country to approve Moderna’s “bivalent” vax, which targets both the original Covid strain and the newer omicron variant. Adults across the pond should have access to the booster this fall. @Vaccine-Med $MRNA (Moderna Inc) $PFE (Pfizer) $BNTX (BioNTech SE) Thank you for... Mostrar más Traducir
Me gusta ComentarCompartir
null
.
Leoandreani03
Amin Harirchian
$RETA (Reata Pharmaceuticals Inc) - Update 𝙒𝙝𝙮 𝙨𝙪𝙘𝙝 𝙖 𝙗𝙞𝙜 𝙙𝙧𝙤𝙥❓ Reata Pharmaceuticals has had a meeting with the US Food Drug Administration (FDA) regarding Omaveloxelone (Omav) for the treatment of Friedreich’s ataxia (FA). The purpose of this meeting was for the FDA to provide Reata... Mostrar más Traducir
Me gusta ComentarCompartir
1 respuesta
null
.
Daniel Rowlands
Editado
📈 Market Update 📈 The S&P500 is now approaching the bull line, which is the point that represents a rise of 20% from the bear market bottom. If the S&P500 was able to pass this point and stay above it for 30 days the bear market cycle would officially be over, and a new bull market would be in place.... Mostrar más Traducir
Me gusta ComentarCompartir
1 respuesta
null
.